Neurological involvement in rheumatoid arthritis

Current Immunology Reviews

Volumn 6, Issue 3, 2010, Pages 174-184

  Ramos Remus, Cesar ^a,b   Duran Barragan, Sergio ^a,c  

^a Unidad de Investigacion en Enfermedades Cronico Degenerativas   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Compression neuropathies; Drug toxicity; Dysautonomia; Entrapment neuropathies; Noncompressive neuropathies; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ANTIMALARIAL AGENT; BETAMETHASONE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; DEXAMETHASONE; ETANERCEPT; GOLD SALT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE; QUINOLINE DERIVATIVE; RITUXIMAB; SALAZOSULFAPYRIDINE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR INHIBITOR;

ASEPTIC MENINGITIS; AUTONOMIC NEUROPATHY; CARPAL TUNNEL SYNDROME; CENTRAL NERVOUS SYSTEM; CEREBELLUM DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; COGNITIVE DEFECT; CONCENTRATION LOSS; CORTICOSTEROID INDUCED MYOPATHY; DEPRESSION; DIZZINESS; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; EXTRAPYRAMIDAL SYNDROME; EYE TOXICITY; GUILLAIN BARRE SYNDROME; HUMAN; HYPOMANIA; LEUKOENCEPHALOPATHY; MANIA; MIXED HEARING LOSS; MOOD CHANGE; MOTOR NEUROPATHY; MYOPATHY; OTOTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOSIS; RETINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SENSORIMOTOR NEUROPATHY; SIDE EFFECT; TINNITUS; TREMOR; VERTIGO;

EID: 77958061117     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339510791823754     Document Type: Review

References (144)

1. Ramos-Remus C, Sierra-Jimenez G, Skeith K, et al. Latitude gradient influences the age of onset in rheumatoid arthritis patients. Clin Rheumatol 2007; 26: 1725-8.
2. Badley EM. Rheumatic diseases: the unnoticed elephant in the room. J Rheumatol 2008; 35: 6-7.
3. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358: 903-11.
4. Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005; 32: 1459-6.
5. Collins DN, Barnes CL, Fitz Randolph RL. Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res 1991; 127-35.
6. Neva MH, Kaarela K, Kauppi M. Prevalence of radiological changes in the cervical spine--a cross sectional study after 20 years from presentation of rheumatoid arthritis. J Rheumatol 2000; 27: 90-3.
7. Fujiwara K, Fujimoto M, Owaki H, et al. Cervical lesions related to the systemic progression in rheumatoid arthritis. Spine (Phila Pa 1976) 1998; 23: 2052-6.
8. Paimela L, Laasonen L, Kankaanpaa E, Leirisalo-Repo M. Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol 1997; 24: 1280-4.
9. Coutts MB. Atlanto-epistropheal subluxation. Arch Surg 1934; 29: 297-311.
10. Babini SM, Cocco JA, Babini JC, de la SM, Arturi A, Marcos JC. Atlantoaxial subluxation in systemic lupus erythematosus: further evidence of tendinous alterations. J Rheumatol 1990; 17: 173-7.
11. Stuart RA, Maddison PJ. Atlantoaxial subluxation in a patient with mixed connective tissue disease. J Rheumatol 1991; 18: 1617-20.
12. Laiho K, Kauppi M. The cervical spine in patients with psoriatic arthritis. Ann Rheum Dis 2002; 61: 650-2.
13. Fox B, Sahuquillo J, Poca MA, Huguet P, Lience E. Reactive arthritis with a severe lesion of the cervical spine. Br J Rheumatol 1997; 36: 126-9.
14. Jordan JM, Obeid LM, Allen NB. Isolated atlantoaxial subluxation as the presenting manifestation of inflammatory bowel disease. Am J Med 1986; 80: 517-20.
15. Koss JC, Dalinka MK. Atlantoaxial subluxation in Behcet's syndrome. Am J Roentgenol 1980; 134: 392-3.
16. Daumen-Legre V, Lafforgue P, Champsaur P, et al. Anteroposterior atlantoaxial subluxation in cervical spine osteoarthritis: case reports and review of the literature. J Rheumatol 1999; 26: 687-91.
17. Takasita M, Matsumoto H, Uchinou S, Tsumura H, Torisu T. Atlantoaxial subluxation associated with ossification of posterior longitudinal ligament of the cervical spine. Spine (Phila Pa 1976) 2000; 25: 2133-6.
18. Verdone F. Anterior atlantoaxial subluxation in a patient with DISH. J Rheumatol 1999; 26: 1639-40.
19. Herzka A, Sponseller PD, Pyeritz RE. Atlantoaxial rotatory subluxation in patients with Marfan syndrome. A report of three cases. Spine (Phila Pa 1976) 2000; 25: 524-6.
20. Shewell PC, Thompson AG. Atlantoaxial instability in Lesch-Nyhan syndrome. Spine (Phila Pa 1976) 1996; 21: 757-62.
21. Bland JH. Rheumatoid subluxation of the cervical spine. J Rheumatol 1990; 17: 134-7.
22. Sharp J, Purser DW. Spontaneous atlanto-axial dislocation in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1961; 20: 47-77.
23. Martel W. The occipito-atlanto-axial joints in rheumatoid arthritis and ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med 1961; 86: 223-40.
24. Castro S, Verstraete K, Mielants H, Vanderstraeten G, de RJ, Veys EM. Cervical spine involvement in rheumatoid arthritis: a clinical, neurological and radiological evaluation. Clin Exp Rheumatol 1994; 12: 369-74.
25. Komusi T, Munro T, Harth M. Radiologic review: the rheumatoid cervical spine. Semin Arthritis Rheum 1985; 14: 187-95.
26. Resnick D, Niwayama G. Anatomy of individual joints. In: Resnick D, editor. Diagnosis of bone and joint disorders. Philadelphia: Saunders 1995; pp. 672-768.
27. Bland JH, Boushey DR. Anatomy and physiology of the cervical spine. Semin Arthritis Rheum 1990; 20: 1-20.
28. Jackson H. The diagnosis of minimal atlanto-axial subluxation. Br J Radiol 1950; 23: 672-4.
29. Hinck VC, Hopkins CE. Measurement of the atlanto-dental interval in the adult. Am J Roentgenol Radium Ther Nucl Med 1960; 84: 945-51.
30. Ramos-Remus C, Gomez-Vargas A, Guzman-Guzman JL, et al. Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol 1995; 22: 2120-5.
31. Ramos-Remus C, Gomez-Vargas A, Hernandez-Chavez A, Gamez-Nava JI, Gonzalez-Lopez L, Russell AS. Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol 1997; 24: 507-10.
32. Boden SD, Dodge LD, Bohlman HH, Rechtine GR. Rheumatoid arthritis of the cervical spine. A long-term analysis with predictors of paralysis and recovery. J Bone Joint Surg Am 1993; 75: 1282-97.
33. Kim DH, Hilibrand AS. Rheumatoid arthritis in the cervical spine. J Am Acad Orthop Surg 2005; 13: 463-74.
34. Kauppi M, Sakaguchi M, Konttinen YT, Hamalainen M. A new method of screening for vertical atlantoaxial dislocation. J Rheumatol 1990; 17: 167-72.
35. Eulderink F, Meijers KA. Pathology of the cervical spine in rheumatoid arthritis: a controlled study of 44 spines. J Pathol 1976; 120: 91-108.
36. Bouchaud-Chabot A, Liote F. Cervical spine involvement in rheumatoid arthritis. A review. Joint Bone Spine 2002; 69: 141-54.
37. Raskin RJ, Schnapf DJ, Wolf CR, Killian PJ, Lawless OJ. Computerized tomography in evaluation of atlantoaxial subluxation in rheumatoid arthritis. J Rheumatol 1983; 10: 33-41.
38. Braunstein EM, Weissman BN, Seltzer SE, Sosman JL, Wang AM, Zamani A. Computed tomography and conventional radiographs of the craniocervical region in rheumatoid arthritis. A comparison. Arthritis Rheum 1984; 27: 26-31.
39. Breedveld FC, Algra PR, Vielvoye CJ, Cats A. Magnetic resonance imaging in the evaluation of patients with rheumatoid arthritis and subluxations of the cervical spine. Arthritis Rheum 1987; 30: 624-9.
40. Stiskal MA, Neuhold A, Szolar DH, et al. Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization. Am J Roentgenol 1995; 165: 585-92.
41. Bell GR, Stearns KL. Flexion-extension MRI of the upper rheumatoid cervical spine. Orthopedics 1991; 14: 969-73.
42. Zikou AK, Alamanos Y, Argyropoulou MI, et al. Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study. J Rheumatol 2005; 32: 801-6.
43. Pisitkun P, Pattarowas C, Siriwongpairat P, Totemchokchyakarn K, Nantiruj K, Janwityanujit S. Reappraisal of cervical spine subluxation in Thai patients with rheumatoid arthritis. Clin Rheumatol 2004; 23: 14-8.
44. Younes M, Belghali S, Kriaa S, et al. Compared imaging of the rheumatoid cervical spine: prevalence study and associated factors. Joint Bone Spine 2009; 76: 361-8.
45. Neva MH, Hakkinen A, Makinen H, Hannonen P, Kauppi M, Sokka T. High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis 2006; 65: 884-88.
46. Messeter KH, Pettersson KI. Endotracheal intubation with the fibre-optic bronchoscope. Anaesthesia 1980; 35: 294-8.
47. Riise T, Jacobsen BK, Gran JT. High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation. J Rheumatol 2001; 28: 2425-9.
48. Paus AC, Steen H, Roislien J, Mowinckel P, Teigland J. High mortality rate in rheumatoid arthritis with subluxation of the cervical spine: a cohort study of operated and nonoperated patients. Spine (Phila Pa 1976) 2008; 33: 2278-83.
49. Shoda N, Seichi A, Takeshita K, et al. Sleep apnea in rheumatoid arthritis patients with occipitocervical lesions: the prevalence and associated radiographic features. Eur Spine J 2009; 18: 905-10.
50. Zikou AK, Argyropoulou MI, Voulgari PV, et al. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab. J Rheumatol 2006; 33: 219-23.
51. Ito H, Neo M, Sakamoto T, Fujibayashi S, Yoshitomi H, Nakamura T. Subaxial subluxation after atlantoaxial transarticular screw fixation in rheumatoid patients. Eur Spine J 2009; 18: 869-76.
52. Mukai Y, Hosono N, Sakaura H, et al. Sagittal alignment of the subaxial cervical spine after C1-C2 transarticular screw fixation in rheumatoid arthritis. J Spinal Disord Tech 2007; 20: 436-41.
53. Mrabet D, Meddeb N, Ajlani H, Sahli H, Sellami S. Cerebral vasculitis in a patient with rheumatoid arthritis. Joint Bone Spine 2007; 74: 201-4.
54. Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS. An unusual presentation of rheumatoid meningitis. J Neuroimaging 2005; 15: 286-88.
55. Bathon JM, Moreland LW, DiBartolomeo AG. Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 1989; 18: 258-66.
56. Markenson JA, McDougal JS, Tsairis P, Lockshin MD, Christian CL. Rheumatoid meningitis: a localized immune process. Ann Intern Med 1979; 90: 786-9.
57. Jackson CG, Chess RL, Ward JR. A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 1984; 11: 237-40.
58. Schmid L, Muller M, Treumann T, et al. Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 2009; 60: 1632-4.
59. Pincus T, Griffith J, Pearce S, Isenberg D. Prevalence of selfreported depression in patients with rheumatoid arthritis. Br J Rheumatol 1996; 35: 879-83.
60. Soderlin MK, Hakala M, Nieminen P. Anxiety and depression in a community-based rheumatoid arthritis population. Scand J Rheumatol 2000; 29: 177-83.
61. Wolfe F, Hawley DJ. The relationship between clinical activity and depression in rheumatoid arthritis. J Rheumatol 1993; 20: 2032-7.
62. Kojima M, Kojima T, Suzuki S, et al. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61: 1018-24.
63. Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006; 65: 285-93.
64. Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 1990; 37: 57-61.
65. Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009; 68: 1119-24.
66. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18.
67. Agarwal V, Singh R, Wiclaf, et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 2008; 27: 841-4.
68. Steinber VL. Neuropathy in rheumatoid disease. Br Med J 1960; 1: 1600-3.
69. Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 1970; 33: 592-604.
70. Pallis CA, Scott JT. Peripheral neuropathy in rheumatoid arthritis. Br Med J 1965; 1: 1141-7.
71. Chamberlain MA, Bruckner FE. Rheumatoid neuropathy. Clinical and electrophysiological features. Ann Rheum Dis 1970; 29: 609-16.
72. Lanzillo B, Pappone N, Crisci C, di GC, Massini R, Caruso G. Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1196-202.
73. Good AE, Christipher RP, Koepke GH, Bender LF, Tarter ME. Peripheral neuropathy associated with rheumatoid arthritis: a clinical and electrodiagnostic study of 70 consecutive rheumatoid arthritis patients. Ann Intern Med 1965; 63: 87-99.
74. Muramatsu K, Tanaka H, Taguchi T. Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment. Rheumatol Int 2008; 28: 951-7.
75. rd ed. New York: Castle Connolly Graduate Medical 2006.
76. Cardenaz Diaz RI, Hernandez Hernandez M, Ramos-Remus C. Anastomosis de Martin-Gruber: Estudio electrofisiológico. Rev Mex Reumatol 1994; 9: 125-29.
77. Boland RA, Kiernan MC. Assessing the accuracy of a combination of clinical tests for identifying carpal tunnel syndrome. J Clin Neurosci 2009; 16: 929-33.
78. El MY, Ashour S, Youssef S, Mehanna A, Meky FA. Clinical diagnosis of carpal tunnel syndrome: old tests-new concepts. Joint Bone Spine 2008; 75: 451-7.
79. Ogawa H, Akaike A, Ishimaru D, et al. Posterior interosseous nerve palsy related to rheumatoid synovitis of the elbow. Mod Rheumatol 2007; 17: 327-9.
80. Sharp RJ, Wade CM, Hennessy MS, Saxby TS. The role of MRI and ultrasound imaging in Morton's neuroma and the effect of size of lesion on symptoms. J Bone Joint Surg Br 2003; 85: 999-1005.
81. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 2006; 36: 88-98.
82. Singhal BS, Khadilkar SV, Gursahani RD, Surya N. Vasculitic neuropathy: profile of twenty patients. J Assoc Physicians India 1995; 43: 459-61.
83. Richter C, Wanke L, Steinmetz J, Reinhold-Keller E, Gross WL. Mononeuritis secondary to rheumatoid arthritis responds to etanercept. Rheumatology (Oxford) 2000; 39: 1436-7.
84. Mayer DF, Matteson EL. Testicular involvement in rheumatoid vasculitis. Clin Exp Rheumatol 2004; 22: S62-S64.
85. Puechal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38: 1618-29.
86. Chatterjee S, Kupsky WJ. Severe proximal myopathy and mononeuritis multiplex in rheumatoid arthritis: manifestations of rheumatoid vasculitis. J Clin Rheumatol 2005; 11: 50-5.
87. Armstrong DJ, McCarron MT, Wright GD. Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab. J Rheumatol 2005; 32: 759-60.
88. Conn DL, McDuffie FC, Dyck PJ. Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 1972; 15: 135-43.
89. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981; 60: 288-97.
90. Schilling U, Muck R, Heidemann E. [Lead poisoning after ingestion of ayurvedic drugs]. Med Klin (Munich) 2004; 99: 476-80.
91. Karri SK, Saper RB, Kales SN. Lead encephalopathy due to traditional medicines. Curr Drug Saf 2008; 3: 54-9.
92. Ruther K, Foerster J, Berndt S, Schroeter J. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses]. Ophthalmologe 2007; 104: 875-9.
93. Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 2003; 110: 1321-6.
94. Rynes RI. Ophthalmologic considerations in using antimalarials in the United States. Lupus 1996; (5 Suppl 1): S73-S74.
95. Rynes RI. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 1997; 36: 799-805.
96. Maturi RK, Yu M, Weleber RG. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 2004; 122: 973-81.
97. Johansen PB, Gran JT. Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol 1998; 16: 472-4.
98. Seckin U, Ozoran K, Ikinciogullari A, Borman P, Bostan EE. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int 2000; 19: 203-4.
99. Hadi U, Nuwayhid N, Hasbini AS. Chloroquine ototoxicity: an idiosyncratic phenomenon. Otolaryngol Head Neck Surg 1996; 114: 491-3.
100. Bernard P. Alterations of auditory evoked potentials during the course of chloroquine treatment. Acta Otolaryngol 1985; 99: 387-92.
101. Scherbel AL, Harrison JW, TDJIAN M. Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Cleve Clin Q 1958; 25: 95-111.
102. th ed. Philadelphia: WB Saunders 1997.
103. Meier CR, Wilcock K, Jick SS. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf 2004; 27: 203-13.
104. Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, Russell AS. Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature. Br J Rheumatol 1995; 34: 166-70.
105. Casado E, Gratacos J, Tolosa C, et al. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 2006; 65: 385-90.
106. Quinn CT, Kamen BA. A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Investig Med 1996; 44: 522-30.
107. Hawboldt J, Bader M. Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 2007; 41: 1906-11.
108. Alloway JA, Mitchell SR. Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. J Rheumatol 1993; 20: 409-11.
109. Tilelli JA, Heinrichs MM. Adverse reactions to parenteral gold salts. Lancet 1997; 349: 853.
110. Fam AG, Gordon DA, Sarkozi J, et al. Neurologic complications associated with gold therapy for rheumatoid arthritis. J Rheumatol 1984; 11: 700-6.
111. Petiot P, Charles N, Vial C, et al. [Neurological complications caused by gold salts. Nosologic report apropos of a case]. Rev Neurol (Paris) 1993; 149: 562-5.
112. Richards BL, Spies J, McGill N, et al. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Intern Med J 2007; 37: 101-7.
113. Bonnel RA, Graham DJ. Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther 2004; 75: 580-5.
114. Martin K, Bentaberry F, Dumoulin C, et al. Neuropathy associated with leflunomide: a case series. Ann Rheum Dis 2005; 64: 649-50.
115. Martin K, Bentaberry F, Dumoulin C, et al. Peripheral neuropathy associated with leflunomide: is there a risk patient profile? Pharmacoepidemiol Drug Saf 2007; 16: 74-8.
116. Bharadwaj A, Haroon N. Peripheral neuropathy in patients on leflunomide. Rheumatology (Oxford) 2004; 43: 934.
117. Goy JJ, Stauffer JC, Deruaz JP, et al. Myopathy as possible sideeffect of cyclosporin. Lancet 1989; 1: 1446-7.
118. Noppen M, Velkeniers B, Dierckx R, Bruyland M, Vanhaelst L. Cyclosporine and myopathy. Ann Intern Med 1987; 107: 945-6.
119. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 2005; 57: 23-34.
120. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. Am J Roentgenol 1995; 165: 627-631.
121. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246: 339-46.
122. Takahashi K, Ogita T, Okudaira H, Yoshinoya S, Yoshizawa H, Miyamoto T. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum 1986; 29: 560-4.
123. Chappel R, Willems J. D-penicillamine-induced myositis in rheumatoid arthritis. Clin Rheumatol 1996; 15: 86-7.
124. Carroll GJ, Will RK, Peter JB, Garlepp MJ, Dawkins RL. Penicillamine induced polymyositis and dermatomyositis. J Rheumatol 1987; 14: 995-1001.
125. Halla JT, Fallahi S, Koopman WJ. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature. Am J Med 1984; 77: 719-22.
126. Benyamin RM, Vallejo R, Kramer J, Rafeyan R. Corticosteroid induced psychosis in the pain management setting. Pain Physician 2008; 11: 917-20.
127. Perantie DC, Brown ES. Corticosteroids, immune suppression, and psychosis. Curr Psychiatry Rep 2002; 4: 171-6.
128. Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 2001; 3: 17-21.
129. Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 2000; 22: 111-22.
130. Singleton JR, Baker BL, Thorburn A. Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis. Endocrinology 2000; 141: 2945-50.
131. Kanda F, Okuda S, Matsushita T, Takatani K, Kimura KI, Chihara K. Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm Res 2001; 56(Suppl 1): 24-8.
132. Price SR. Increased transcription of ubiquitin-proteasome system components: molecular responses associated with muscle atrophy. Int J Biochem Cell Biol 2003; 35: 617-28.
133. Lozeron P, Denier C, Lacroix C, Adams D. Long-term course of demyelinating neuropathies occurring during tumor necrosis factoralpha-blocker therapy. Arch Neurol 2009; 66: 490-7.
134. Kur-Zalewska J, Swarowska-Knap J, Tlustochowicz W. Neurological disorders with demyelinating brain white matter lesions in a patient with rheumatoid arthritis treated with etanercept. Pol Arch Med Wewn 2008; 118: 234-7.
135. Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 2001; 44: 2862-9.
136. Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN. Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 2006; 54: 1429-34.
137. Calabrese LH, Molloy ES. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 2008; 67 Suppl 3: iii64-iii65.
138. Food and Drug Administration 9 A.D. June 19 [cited 9 A.D. Aug 6]; Available from: URL: http: //www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150747.htm
139. Carson KR, Focosi D, Major EO, et al. Monoclonal antibodyassociated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 2009; 10: 816-4.
140. Lima MA, Drislane FW, Koralnik IJ. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006; 66: 262-4.
141. Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Aseptic meningitis, psychosis, and cognitive dysfunction. Arch Intern Med 1991; 151: 1309-13.
142. Rodriguez SC, Olguin AM, Miralles CP, Viladrich PF. Characteristics of meningitis caused by Ibuprofen: report of 2 cases with recurrent episodes and review of the literature. Medicine (Baltimore) 2006; 85: 214-20.
143. Simon LS, Mills JA. Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts). N Engl J Med 1980; 302: 1179-1185.
144. Horn AC, Jarrett SW. Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. Ann Pharmacother 1997; 31: 1009-11.